Better Health Worldwide, Inc.
  • About
    • About Us
    • Blog
    • BH-WW in Action
  • Data & Analytics
    • Data Access, Analysis & Communications
    • Data Collection & Datasets
    • Disease Awareness
    • Market Research
  • Communications
    • Publications
    • Advisory Boards & Panels
    • Medical Science Liaisons
  • Contact
  • 📞 (973) 208-8621
Select Page

Prescription medications during patients’ journey to the diagnosis of facioscapulohumeral muscular dystrophy: a real-world retrospective data analysis

Mar 24, 2022

Prescription Medications used by Patients with Myotonic Dystrophy Types 1 and 2 (DM) Prior to Diagnosis; a Real-World data analysis [Gold Ribbon]

Mar 24, 2022

Understanding the Patients’ Journey Pre‑ and Post-Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD): a Real-World Retrospective Data Analysis

Mar 17, 2022

Prevalence of Healthcare Conditions and Services Used by Patients with Myotonic Dystrophy (DM) Pre- and Post-Diagnosis: a Real-World Data Analysis

Mar 17, 2022

Clinical and Economic Burden of Employees Who Are Care Partners of Patients with Multiple Sclerosis

Nov 17, 2021

« Older Entries

Recent Posts

  • The Rarity of Rare Diseases
  • A Late Spring
  • Did the Meeting Really Happen?
  • Spring is in the Air—and what else?
  • Facebook
  • LinkedIn
©2022 Better Health Worldwide, All rights reserved.